NCT00668083已完成不适用
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 214
- 试验地点
- 2
- 主要终点
- Hormonal sensitivity to second line treatment for CaP after Bicalutamide
研究概览
简要总结
Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •non metastatic Prostate Cancer
- •previous treatment with bicalutamide 150mg
- •biochemical relapse/progression
排除标准
- •use of other treatments for Prostate Cancer
结局指标
主要结局
Hormonal sensitivity to second line treatment for CaP after Bicalutamide
时间窗: six months
次要结局
- median duration of second and third line treatments;(six months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With ChemotherapyCancer of ProstateProstatic CancerCancer of the ProstateProstate CancerNCT00257478Astellas Pharma Inc
已完成
不适用
Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant StateProstate CancerNCT01560858Ipsen407
Unknown
3 期
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate CancerProstate CancerNCT00003734St. Luke's Hospital, Ireland276
已完成
3 期
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate CancerProstate CancerNCT00003653NCIC Clinical Trials Group1,386
已完成
3 期
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerProstate CancerNCT00002881Eastern Cooperative Oncology Group